Health Catalyst Capital Annex Fund II, L.P. — Form D
Health Catalyst Capital Annex Fund II, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-12-06. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-12-06
- Form: D
- Accession: 0001012975-24-000515
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $4.0M
- Amount sold: $4.0M
- Minimum investment: $4.0M
- Investors: 1
- Date of first sale: 2024-11-25
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-531283
Issuer
- Name: Health Catalyst Capital Annex Fund II, L.P.
- CIK: 0002046335
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 515 MADISON AVENUE, NEW YORK, NY, 10022
- Phone: 212-752-2226
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| N/A Health Catalyst Associates Annex, LLC | Director | New York, NY |
| Charles Boorady | Executive Officer | Brentwood, TN |
| Daniel Ross | Executive Officer | Provo, UT |
More